Skip to main content

2 Result(s)

within **aosheng He MD Remove this filter

and

  1. No Access

    Article

    A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer

    The purpose of this study was to develop an in situ immune marker model to predict postoperative oncological outcomes in patients with colorectal cancer (CRC).

    Yufeng Chen MD, Ruixue Yuan PhD, … in Annals of Surgical Oncology (2016)

  2. No Access

    Article

    Significance of mTOR Signaling and Its Inhibitor Against Cancer Stem-Like Cells in Colorectal Cancer

    To determine the role of the mammalian target of rapamycin (mTOR) signaling in sustaining cancer stem-like cells and its clinical values in colorectal cancer (CRC).

    Zerong Cai MD, Jia Ke MD, **aosheng He MD, Ruixue Yuan PhD… in Annals of Surgical Oncology (2014)